The device, called the Abbott Gallant, is a biventricular implantable cardiac defibrillator that earned FDA approval in July and is the first to wirelessly pair with a smartphone app for patients.
Mohamad Sinno, MD, a cardiac electrophysiology specialist at St. Elizabeth Edgewood, led the procedure.
Learn more here.
More articles on cardiology:
Potential COVID-19 treatment could increase cardiac event risk if taken with certain drugs
NewYork-Presbyterian Brooklyn Methodist Hospital names new cardiology chief
Journal of Invasive Cardiology to go 100% digital
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
